Advertiser / Brand
AbbVie vs Hasbro
Structured technology and market comparison · 2026
Direct Feature Comparison
AbbVie · vs · HasbroBiopharmaceutical company developing and commercialising prescription medicines.
Toy, games, and entertainment IP company.
Analyze all overlapping signals and tech stacks for AbbVie and Hasbro
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between AbbVie and Hasbro?
When comparing AbbVie and Hasbro, both platforms operate within the Advertiser / Brand ecosystem. AbbVie is positioned as Biopharmaceutical company developing and commercialising prescription medicines, whereas Hasbro focuses on Toy, games, and entertainment IP company. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to AbbVie and Hasbro?
When evaluating AbbVie and Hasbro, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of AbbVie and Hasbro compare?
AbbVie is headquartered in US (founded in 2012) with >5,000 employees. Hasbro is based in US (founded in 1923) with 1,001–5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: AbbVie vs Hasbro
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
AbbVie
Recent Signals
- ·AbbVie
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
EPCORE DLBCL-2 is the first Phase 3 study of a bispecific antibody combination therapy to demonstrate statistically significant and clinically meaningful improvement in progression-free survival...
- ·AbbVie
U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease. Taken once daily with or without levodopa therapy, JUVMO offers patients a...
- ·AbbVie
AbbVie Participates in USTR’s Section 301 Investigation into Germany to Address Global Imbalances in How Transformative Medicines are Valued
On behalf of AbbVie, Perry Siatis, Executive Vice President, General Counsel and Secretary, testified in front of the U.S. Trade Representative (USTR) on...
Hasbro
Recent Signals
- ·Retail DiveFinancials
Hasbro's Magic: The Gathering Hits Record $600M Quarterly Revenue
Hasbro reported third-quarter 2026 results with Magic: The Gathering exceeding $600 million in quarterly revenue for the first time. Total Hasbro Q3 net sales were $1.5 billion, up 17.5% year-over-year, marking the fourth consecutive quarter of double-digit growth. The company raised its full-year revenue outlook to between 7% and 9% growth. Licensing revenue was $144 million for the quarter. Hasbro also highlighted the pre-release of The Hobbit set as one of its biggest ever, and noted the launch of its AI studio, Sixth Wall, which focuses on behavioral licensing of its IP.
- Magic: The Gathering revenue surpassed $600 million in Q3 2026, a 34% year-over-year increase.
- Hasbro's Q3 2026 net sales were $1.5 billion, up 17.5% year-over-year.
- Hasbro raised its full-year 2026 revenue outlook to 7-9% growth.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Hasbro (2026-10-20)
On October 20, 2026, Hasbro, Inc. submitted a Form 8-K under Item 2.02 to announce its financial results for the fiscal third quarter ended September 27, 2026. The full earnings details and operational performance metrics were furnished via Exhibit 99.1. The filing serves as the formal SEC notification of the company's quarterly financial performance, signed by Chief Financial Officer and Chief Operating Officer Gina Goetter.
- Hasbro furnished its financial results for the fiscal quarter ended September 27, 2026, via an earnings press release included as Exhibit 99.1.
- The filing was executed and signed on October 20, 2026, by Gina Goetter, Chief Financial Officer and Chief Operating Officer.
- The disclosure was submitted under Item 2.02 (Results of Operations and Financial Condition) and is furnished rather than filed under SEC statutes.
- ·Cord Cutters NewsDistribution, FAST Channel
Hasbro Legends FAST Channel Expands to Plex Streaming Platform
Hasbro Legends, a free ad-supported streaming television channel featuring classic Hasbro programming, has expanded its distribution to the Plex platform. The channel, owned by Get After It Media and programmed with content from Hasbro Entertainment, launched over-the-air in July 2026 and is now available on multiple streaming platforms including Heartland+ and Amazon Prime Video's live TV guide. The Plex addition provides another nationwide, subscription-free entry point for viewers. The channel offers nostalgic animated series such as G.I. Joe, Transformers, Power Rangers, My Little Pony, and more, with a schedule evolving towards themed marathon blocks. The distribution strategy aims to reach audiences through multiple free pathways, leveraging both broadcast television and streaming services.
- Hasbro Legends launched over-the-air on July 13, 2026, covering 70 U.S. markets.
- The channel is available on Plex, Heartland+, and Amazon Prime Video's live TV guide.
- Initial coverage reached 70.8 million TV households (over 55% of U.S. TV households).
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners AbbVie and Hasbro share across the market ecosystem.
